Baker Tilly Wealth Management, LLC Bristol Myers Squibb CO Transaction History
Baker Tilly Wealth Management, LLC
- $429 Million
- Q3 2025
A detailed history of Baker Tilly Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Baker Tilly Wealth Management, LLC holds 6,528 shares of BMY stock, worth $283,249. This represents 0.07% of its overall portfolio holdings.
Number of Shares
6,528
Previous 5,894
10.76%
Holding current value
$283,249
Previous $272,000
8.09%
% of portfolio
0.07%
Previous 0.1%
Shares
20 transactions
Others Institutions Holding BMY
# of Institutions
2,672Shares Held
1.63BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.46 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$6.88 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.69 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.11 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.07 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $92.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...